Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

855 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment of coronary bifurcation lesions with bioresorbable vascular scaffolds.
Capranzano P, Gargiulo G, Capodanno D, Longo G, Tamburino C, Ohno Y, Attizzani GF, La Manna A, Di Salvo M, Francaviglia B, Grasso C, Sgroi C, Tamburino C. Capranzano P, et al. Among authors: longo g. Minerva Cardioangiol. 2014 Jun;62(3):229-34. Minerva Cardioangiol. 2014. PMID: 24831758 Clinical Trial.
Bioresorbable vascular scaffold in patients with complex coronary artery disease.
Tamburino CI, Capranzano P, Longo G, Immè S, Tamburino G, Scalia M, Condorelli A, Francaviglia B, LA Manna A, Sgroi C, Grasso C, DI Salvo ME, Capodanno D, Tamburino C. Tamburino CI, et al. Among authors: longo g. Minerva Cardioangiol. 2016 Aug;64(4):481-6. Epub 2016 Apr 29. Minerva Cardioangiol. 2016. PMID: 27128353 Review.
One-Year Clinical Outcomes of Forty-Eight Millimeter Everolimus-Eluting Stent Implanted in Very Long Lesions: A Propensity-Matched Comparison (The FREIUS Study).
Secco GG, Tebaldi M, Parisi R, Cuculo A, Di Mario C, Sangiorgio P, Ielasi A, Centola A, Fattori R, Vercellino M, Longo G, Pistis G, Biscaglia S, Ruggiero A, Marino PN, Campo G. Secco GG, et al. Among authors: longo g. J Invasive Cardiol. 2018 Apr;30(4):133-137. J Invasive Cardiol. 2018. PMID: 29610443 Free article.
Procedural and Long-Term Outcomes of Bioresorbable Scaffolds Versus Drug-Eluting Stents in Chronic Total Occlusions: The BONITO Registry (Bioresorbable Scaffolds Versus Drug-Eluting Stents in Chronic Total Occlusions).
Azzalini L, Giustino G, Ojeda S, Serra A, La Manna A, Ly HQ, Bellini B, Benincasa S, Chavarría J, Gheorghe LL, Longo G, Miccichè E, D'Agosta G, Picard F, Pan M, Tamburino C, Latib A, Carlino M, Chieffo A, Colombo A. Azzalini L, et al. Among authors: longo g. Circ Cardiovasc Interv. 2016 Oct;9(10):e004284. doi: 10.1161/CIRCINTERVENTIONS.116.004284. Circ Cardiovasc Interv. 2016. PMID: 27765802
Everolimus-eluting bioresorbable vascular scaffolds versus second generation drug-eluting stents for percutaneous treatment of chronic total coronary occlusions: Technical and procedural outcomes from the GHOST-CTO registry.
La Manna A, Chisari A, Giacchi G, Capodanno D, Longo G, Di Silvestro M, Capranzano P, Tamburino C. La Manna A, et al. Among authors: longo g. Catheter Cardiovasc Interv. 2016 Nov 15;88(6):E155-E163. doi: 10.1002/ccd.26397. Epub 2016 Jan 12. Catheter Cardiovasc Interv. 2016. PMID: 26756959
855 results